| Aug 12 |
Should You Add 60 Degrees Pharmaceuticals, Inc. (SXTP) to Your Stock Portfolio Right Now?
|
| Aug 12 |
60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study
|
| Aug 6 |
60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split
|
| Jul 25 |
60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
|
| Jul 22 |
60 Degrees Pharmaceuticals enters deals for babesiosis treatment trial
|
| Jul 19 |
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
|
| Jul 19 |
Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
|
| Jul 12 |
60 Degrees Pharmaceuticals files mixed shelf offering of up to $15M
|
| Jul 9 |
60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment
|
| Jun 27 |
First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind
|
